IL6 and COVID-19: The mechanism by which COVID-19 may cause CAV is not fully understood, but it is thought to be related to the release of pro-inflammatory cytokines such as interleukin 6 and endothelial injury via angiotensin-converting enzyme receptors on the endothelial surface [4-6].